Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)

Zealand Pharma issued a correction to its share buy-back program announcement for week 35 (August 24-28, 2026), updating transaction dates in the reporting table. During this period, the company repurchased 136,000 shares at an average price of DKK 318.99, bringing total accumulated repurchases to 2,863,000 shares (approximately 5.22% of share capital) valued at DKK 868.6 million under the DKK 1.3 billion program.